 Connection
Shitiz Sriwastava to Leukoencephalopathy, Progressive Multifocal
This is a "connection" page, showing publications Shitiz Sriwastava has written about Leukoencephalopathy, Progressive Multifocal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.751 |
|
|
|
-
Sharma K, Tolaymat S, Yu H, Elkhooly M, Jaiswal S, Jena A, Kakara M, Sriwastava S. Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review. J Neurol Sci. 2022 12 15; 443:120459.
Score: 0.785
-
Yu H, Wu H, R S, Kaur A, Pasham SR, Upadhaya R, Sriwastava S. Single-center experience on progressive multifocal leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU). J Med Virol. 2022 08; 94(8):4015-4022.
Score: 0.760
-
Sriwastava S, Khan E, Khalid SH, Kaur A, Feizi P. Progressive multifocal leukoencephalopathy in an immunocompetent patient: A case report and review of literature. J Med Virol. 2022 06; 94(6):2860-2869.
Score: 0.740
-
Sriwastava S, Chaudhary D, Srivastava S, Beard K, Bai X, Wen S, Khalid SH, Lisak RP. Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature. J Neurol. 2022 Mar; 269(3):1678-1687.
Score: 0.737
-
Sriwastava S, Kataria S, Srivastava S, Kazemlou S, Gao S, Wen S, Saber H, Tripathi R, Sheikh Z, Peterson S, Gwinn R, Bernitsas E. Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis. J Neuroimmunol. 2021 11 15; 360:577721.
Score: 0.728
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|